Jiangxi Rimag Group Acquires Majority Stake in Gaomai Health for RMB 54 Million

Reuters

2025/06/22

Jiangxi Rimag Group Acquires Majority Stake in Gaomai Health for RMB 54 Million

Jiangxi Rimag Group Co., Ltd. has announced its acquisition of a majority stake in Guangzhou Gaomai Health Technology Co., Ltd. The transaction, involving Jiangxi Ganjiang New Area Rimag Health Management Limited, a wholly-owned subsidiary of Jiangxi Rimag Group, will see the purchase of 30.0%, 20.0%, and 20.0% equity interests from Guangdong Gaoshang Health Technology Group Co., Ltd., Xiamen Gaoshang Medical Imaging Diagnostic Center Co., Ltd., and Hefei Gaoshang Medical Imaging Diagnostic Center Co., Ltd., respectively. The total consideration for the acquisition is RMB54,000,000. Following the completion of this deal, Jiangxi Rimag will hold a 70.0% equity interest in Gaomai Health, making it a subsidiary of Jiangxi Rimag Group, with its financial results to be consolidated into the group's financial statements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangxi Rimag Group Co. Ltd. published the original content used to generate this news brief on June 22, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2545431097"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2545431097\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2545431097?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-22 18:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2545431097","market":"us","top_or_hot":-1,"title":"Jiangxi Rimag Group Acquires Majority Stake in Gaomai Health for RMB 54 Million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Jiangxi Rimag Group Acquires Majority Stake in Gaomai Health for RMB 54 Million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Jiangxi Rimag Group Co., Ltd. has announced its acquisition of a majority stake in Guangzhou Gaomai Health Technology Co., Ltd. The transaction, involving Jiangxi Ganjiang New Area Rimag Health Management Limited, a wholly-owned subsidiary of Jiangxi Rimag Group, will see the purchase of 30.0%, 20.0%, and 20.0% equity interests from Guangdong Gaoshang Health Technology Group Co., Ltd., Xiamen Gaoshang Medical Imaging Diagnostic Center Co., Ltd., and Hefei Gaoshang Medical Imaging Diagnostic Center Co., Ltd., respectively. The total consideration for the acquisition is RMB54,000,000. Following the completion of this deal, Jiangxi Rimag will hold a 70.0% equity interest in Gaomai Health, making it a subsidiary of Jiangxi Rimag Group, with its financial results to be consolidated into the group's financial statements.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangxi Rimag Group Co. Ltd. published the original content used to generate this news brief on June 22, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jiangxi Rimag Group Acquires Majority Stake in Gaomai Health for RMB 54 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJiangxi Rimag Group Acquires Majority Stake in Gaomai Health for RMB 54 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-22 18:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Jiangxi Rimag Group Acquires Majority Stake in Gaomai Health for RMB 54 Million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Jiangxi Rimag Group Co., Ltd. has announced its acquisition of a majority stake in Guangzhou Gaomai Health Technology Co., Ltd. The transaction, involving Jiangxi Ganjiang New Area Rimag Health Management Limited, a wholly-owned subsidiary of Jiangxi Rimag Group, will see the purchase of 30.0%, 20.0%, and 20.0% equity interests from Guangdong Gaoshang Health Technology Group Co., Ltd., Xiamen Gaoshang Medical Imaging Diagnostic Center Co., Ltd., and Hefei Gaoshang Medical Imaging Diagnostic Center Co., Ltd., respectively. The total consideration for the acquisition is RMB54,000,000. Following the completion of this deal, Jiangxi Rimag will hold a 70.0% equity interest in Gaomai Health, making it a subsidiary of Jiangxi Rimag Group, with its financial results to be consolidated into the group's financial statements.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangxi Rimag Group Co. Ltd. published the original content used to generate this news brief on June 22, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1219","symbol_name":"保健护理服务","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250622:nNDLq7B8B:1","article_id":"2545431097","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2545431097","pubTimestamp":1750587917,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Jiangxi Rimag Group Co., Ltd. has announced its acquisition of a majority stake in Guangzhou Gaomai Health Technology Co., Ltd. The transaction, involving Jiangxi Ganjiang New Area Rimag Health Management Limited, a wholly-owned subsidiary of Jiangxi Rimag Group, will see the purchase of 30.0%, 20.0%, and 20.0% equity interests from Guangdong Gaoshang Health Technology Group Co., Ltd., Xiamen Gaoshang Medical Imaging Diagnostic Center Co., Ltd., and Hefei Gaoshang Medical Imaging Diagnostic Center Co., Ltd., respectively. The total consideration for the acquisition is RMB54,000,000. Following the completion of this deal, Jiangxi Rimag will hold a 70.0% equity interest in Gaomai Health, making it a subsidiary of Jiangxi Rimag Group, with its financial results to be consolidated into the group's financial statements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300253":"卫宁健康","BK1219":"保健护理服务","MMS":"马克西姆斯服务","BK0146":"智慧医疗","BK0028":"国家队","BK0020":"浦东新区","BK0077":"质押式回购","BK0058":"智慧城市","02522":"一脉阳光","BK0114":"健康中国","BK0231":"软件信息","BK0188":"融资融券","BK4106":"数据处理与外包服务","BK4226":"数据处理及外包服务"},"translate_title":"江西瑞玛格集团5400万收购高迈健康多数股权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300253":0.9,"MMS":0.9,"02522":0.9},"content_text":"Jiangxi Rimag Group Acquires Majority Stake in Gaomai Health for RMB 54 Million\n    \n\n        Jiangxi Rimag Group Co., Ltd. has announced its acquisition of a majority stake in Guangzhou Gaomai Health Technology Co., Ltd. The transaction, involving Jiangxi Ganjiang New Area Rimag Health Management Limited, a wholly-owned subsidiary of Jiangxi Rimag Group, will see the purchase of 30.0%, 20.0%, and 20.0% equity interests from Guangdong Gaoshang Health Technology Group Co., Ltd., Xiamen Gaoshang Medical Imaging Diagnostic Center Co., Ltd., and Hefei Gaoshang Medical Imaging Diagnostic Center Co., Ltd., respectively. The total consideration for the acquisition is RMB54,000,000. Following the completion of this deal, Jiangxi Rimag will hold a 70.0% equity interest in Gaomai Health, making it a subsidiary of Jiangxi Rimag Group, with its financial results to be consolidated into the group's financial statements.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangxi Rimag Group Co. Ltd. published the original content used to generate this news brief on June 22, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}